Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2016 · 10-Q
Revenue$0.00$0.00— vs Q2 2015 Net Income-$528.07K-$528.07KN/M vs Q2 2015 EPS Diluted$0.00$0.00— vs Q2 2015 Operating Income-$500,706N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$355,090N/M ended Jun 30, 2016 · filed Aug 12, 2016 · 43 d after period end